Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Protein Analysis Reagents
  4. Bioactive Small Molecules
  5. 630050

Tocris Bioscience™ Thalidomide 4'-oxyacetamide-alkylC4-azide
GREENER_CHOICE

Catalog No. 630050
Change view
Click to view available options
Quantity:
50 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
63-005-0 50 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 63-005-0 Supplier Tocris Bioscience™ Supplier No. 6300/50
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

Description

Azide-functionalized Thalidomide; click cereblon ligand for PROTACs

Thalidomide 4'-oxyacetamide-alkylC4-azide is a click-activated Thalidomide (Cat.No. 0652); precursor to PROTAC® that hijacks cereblon as the E3 ubiquitin ligase component. Supplied with an azide functional handle at a position known not to significantly affect binding to cereblon, for ready click conjugation to a linker/target protein ligand.

This product has been recently renamed. The previous name for this product was Azido-Thalidomide

Please contact us for SD files of our available Degrader Building Blocks.

PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.

Specifications

CAS 2098488-36-7
Synonym Azido-Thalidomide
Quantity 50 mg
Target Degrader Building Blocks
Molecular Formula C19H20N6O6
Formula Weight 428.4
Purity 98%
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.